Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
- PMID: 31361627
- PMCID: PMC6735526
- DOI: 10.1097/WCO.0000000000000730
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Abstract
Purpose of review: The cause of amyotrophic lateral sclerosis (ALS) remains unknown for most of the patients with the disease. Epidemiologic studies can help describe disease burden and examine its potential risk factors, providing thereby evidence base for future mechanistic studies. With this review, we aimed to provide a summary of epidemiologic studies published during the past 18 months, which studied the incidence and risk factors for ALS.
Recent findings: An increasing incidence and prevalence of ALS continue to be reported from different parts of the world. Several previously studied risk factors are confirmed as causally related to ALS by Mendelian randomization analysis. The previously known prognostic indicators for ALS appear to be the same across populations.
Summary: Provided with the increasing number of patients diagnosed with ALS and the improved societal awareness of the disease, more resources should be allocated to the research and care of ALS. Population-based studies, especially population-based disease registers, should be the priorities in ALS research, and more data from outside Europe are needed in gaining a better global perspective of the disease.
Similar articles
-
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.MMWR Surveill Summ. 2016 Aug 5;65(8):1-12. doi: 10.15585/mmwr.ss6508a1. MMWR Surveill Summ. 2016. PMID: 27490513
-
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.MMWR Suppl. 2014 Jul 25;63(7):1-14. MMWR Suppl. 2014. PMID: 25054277
-
The epidemiology of amyotrophic lateral sclerosis.Handb Clin Neurol. 2016;138:225-38. doi: 10.1016/B978-0-12-802973-2.00013-6. Handb Clin Neurol. 2016. PMID: 27637961 Review.
-
Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference.Neuroepidemiology. 2019;52(1-2):93-103. doi: 10.1159/000493386. Epub 2019 Jan 2. Neuroepidemiology. 2019. PMID: 30602169 Review.
-
The changing picture of amyotrophic lateral sclerosis: lessons from European registers.J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):557-563. doi: 10.1136/jnnp-2016-314495. Epub 2017 Mar 11. J Neurol Neurosurg Psychiatry. 2017. PMID: 28285264 Review.
Cited by
-
Evaluation of the Hematological and Serum Biochemistry Parameters in the Pre-Symptomatic and Symptomatic Stages of ALS Disease to Support Early Diagnosis and Prognosis.Cells. 2022 Nov 11;11(22):3569. doi: 10.3390/cells11223569. Cells. 2022. PMID: 36428998 Free PMC article.
-
Physical therapy for the management of motor symptoms in amyotrophic lateral sclerosis: protocol for a systematic review.BMJ Open. 2022 Nov 22;12(11):e063689. doi: 10.1136/bmjopen-2022-063689. BMJ Open. 2022. PMID: 36414305 Free PMC article.
-
Physical therapy for muscle strengthening in individuals with amyotrophic lateral sclerosis: A protocol for a systematic review and meta-analysis.PLoS One. 2024 Jul 22;19(7):e0307470. doi: 10.1371/journal.pone.0307470. eCollection 2024. PLoS One. 2024. PMID: 39037980 Free PMC article.
-
Passive Transfer of Sera from ALS Patients with Identified Mutations Evokes an Increased Synaptic Vesicle Number and Elevation of Calcium Levels in Motor Axon Terminals, Similar to Sera from Sporadic Patients.Int J Mol Sci. 2020 Aug 3;21(15):5566. doi: 10.3390/ijms21155566. Int J Mol Sci. 2020. PMID: 32756522 Free PMC article.
-
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials.Pharmaceutics. 2023 Jan 7;15(1):212. doi: 10.3390/pharmaceutics15010212. Pharmaceutics. 2023. PMID: 36678841 Free PMC article. Review.
References
-
- Longinetti E, Regodon Wallin A, Samuelsson K, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener 2018; 19:528–537. - PubMed
-
A population-based study using data from a national MND registry that highlights the need of setting up national registries to identify and care for ALS patients.
-
- Palese F, Sartori A, Verriello L, et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002–2014: a retrospective population-based study. Amyotroph Lateral Scler Frontotemporal Degener 2019; 20:90–99. - PubMed
-
- Benjaminsen E, Alstadhaug KB, Gulsvik M, et al. Amyotrophic lateral sclerosis in Nordland County, Norway, 2000–2015: prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener 2018; 19:522–527. - PubMed
-
- Turgut N, Birgili O, Varol SaraCoglu G, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006–2010. Amyotroph Lateral Scler Frontotemporal Degener 2019; 20:100–106. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous